Related references
Note: Only part of the references are listed.A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil
Paulo R. L. Machado et al.
CLINICAL INFECTIOUS DISEASES (2021)
Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake
Caroline R. Espada et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
Juliana B. T. Carnielli et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis
Zahra Rezaei et al.
PARASITES & VECTORS (2019)
What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil
Fernando T. Silveiraa
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Production of a kinesin-related recombinant protein (Lbk39) from Leishmania braziliensis by Leishmania tarentolae promastigotes and its application in the serodiagnosis of leishmaniasis
Ligia Moraes Barizon de Souza et al.
ONE HEALTH (2019)
Chemotherapy of leishmaniasis: present challenges
Silvia R. B. Uliana et al.
PARASITOLOGY (2018)
Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most
Temmy Sunyoto et al.
BMJ GLOBAL HEALTH (2018)
Achievement of constitutive fluorescent pLEXSY-egfp Leishmania braziliensis and its application as an alternative method for drug screening in vitro
Matheus Silva e Bastos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)
Evidence of putative non-coding RNAs from Leishmania untranslated regions
Felipe Freitas Castro et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2017)
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Saumya Srivastava et al.
PARASITES & VECTORS (2017)
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
Tom Beneke et al.
ROYAL SOCIETY OPEN SCIENCE (2017)
The cytotoxic activity of miltefosine against Leishmania and macrophages is associated with dynamic changes in plasma membrane proteins
Kelly Souza Fernandes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis
Carolina Cincura et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Gene expression in Kinetoplastids
C. E. Clayton
CURRENT OPINION IN MICROBIOLOGY (2016)
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
C. D. Shaw et al.
MOLECULAR MICROBIOLOGY (2016)
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
Annelies Mondelaers et al.
PLOS ONE (2016)
Functional role of evolutionarily highly conserved residues, N-glycosylation level and domains of the Leishmania miltefosine transporter-Cdc50 subunit
Sebastian Garcia-Sanchez et al.
BIOCHEMICAL JOURNAL (2014)
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
Adriano C. Coelho et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
Suman Rijal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Generation of Leishmania Hybrids by Whole Genomic DNA Transformation
Adriano C. Coelho et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Leishmania Resistance to Miltefosine Associated with Genetic Marker
Sandrine Cojean et al.
EMERGING INFECTIOUS DISEASES (2012)
Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil
Anette Chrusciak-Talhari et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Tim Downing et al.
GENOME RESEARCH (2011)
Purification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoan Leishmania tarentolae
Emerich Mihai Gazdag et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2010)
Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
Paulo R. Machado et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Low Plasma Membrane Expression of the Miltefosine Transport Complex Renders Leishmania braziliensis Refractory to the Drug
Maria P. Sanchez-Canete et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum
Philippe Leprohon et al.
NUCLEIC ACIDS RESEARCH (2009)
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients
Thomas P. C. Dorlo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine
Valentin Hornillos et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Global gene expression in Leishmania
Gabriela Cohen-Freue et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites
F. Javier Perez-Victoria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Trypanosomatid protozoa: A simplified DNA isolation procedure
B Rotureau et al.
EXPERIMENTAL PARASITOLOGY (2005)
Functional cloning of the miltefosine transporter -: A novel P-type phospholipid translocase from Leishmania involved in drug resistance
FJ Pérez-Victoria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine
PK Hanson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug
FJ Pérez-Victoria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil
E Cupolillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
